BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 38198357)

  • 1. Endothelium-specific SIRT7 targeting ameliorates pulmonary hypertension through Krüpple-like factor 4 deacetylation.
    Zhang J; Xu C; Tang X; Sun S; Liu S; Yang L; Chen Y; Yang Q; Wei TW; Wu X; Wang J; Wang C; Yan X; Yang L; Niu Y; Gou D; Shyy JYJ; Liu B
    Cardiovasc Res; 2024 Mar; 120(4):403-416. PubMed ID: 38198357
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypoxia activates GPR146 which participates in pulmonary vascular remodeling by promoting pyroptosis of pulmonary artery endothelial cells.
    Jiang Y; Huang J; Xia Y; Sun Z; Hu P; Wang D; Liu Y; Tao T; Liu Y
    Eur J Pharmacol; 2023 Feb; 941():175502. PubMed ID: 36638952
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endothelial Krüppel-like factor 4 modulates pulmonary arterial hypertension.
    Shatat MA; Tian H; Zhang R; Tandon G; Hale A; Fritz JS; Zhou G; Martínez-González J; Rodríguez C; Champion HC; Jain MK; Hamik A
    Am J Respir Cell Mol Biol; 2014 Mar; 50(3):647-53. PubMed ID: 24156273
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MED1 Regulates BMP/TGF-β in Endothelium: Implication for Pulmonary Hypertension.
    Wang C; Xing Y; Zhang J; He M; Dong J; Chen S; Wu H; Huang HY; Chou CH; Bai L; He F; She J; Su A; Wang Y; Thistlethwaite PA; Huang HD; Yuan JX; Yuan ZY; Shyy JY
    Circ Res; 2022 Oct; 131(10):828-841. PubMed ID: 36252121
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nanoparticle endothelial delivery of PGC-1α attenuates hypoxia-induced pulmonary hypertension by attenuating EndoMT-caused vascular wall remodeling.
    Cai D; Chen SY
    Redox Biol; 2022 Dec; 58():102524. PubMed ID: 36334380
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endothelial downregulation of nuclear m6A reader YTHDC1 promotes pulmonary vascular remodeling in sugen hypoxia model of pulmonary hypertension.
    Zheng H; Wu D; Chen X; He W; Hua J; Li Q; Ji Y
    Heliyon; 2024 Feb; 10(3):e24963. PubMed ID: 38318069
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peroxisome Proliferator-Activated Receptor γ and microRNA 98 in Hypoxia-Induced Endothelin-1 Signaling.
    Kang BY; Park KK; Kleinhenz JM; Murphy TC; Green DE; Bijli KM; Yeligar SM; Carthan KA; Searles CD; Sutliff RL; Hart CM
    Am J Respir Cell Mol Biol; 2016 Jan; 54(1):136-46. PubMed ID: 26098770
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CCL5 deficiency rescues pulmonary vascular dysfunction, and reverses pulmonary hypertension via caveolin-1-dependent BMPR2 activation.
    Nie X; Tan J; Dai Y; Liu Y; Zou J; Sun J; Ye S; Shen C; Fan L; Chen J; Bian JS
    J Mol Cell Cardiol; 2018 Mar; 116():41-56. PubMed ID: 29374556
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Established pulmonary hypertension in rats was reversed by a combination of a HIF-2α antagonist and a p53 agonist.
    Zheng Q; Lu W; Yan H; Duan X; Chen Y; Zhang C; Luo X; Chen J; Wang C; Liu S; Li Y; Tang H; Rahimi S; Rahimi S; Yuan JX; Zhong N; Yang K; Wang J
    Br J Pharmacol; 2022 Mar; 179(5):1065-1081. PubMed ID: 34599843
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PDGF-BB/KLF4/VEGF Signaling Axis in Pulmonary Artery Endothelial Cell Angiogenesis.
    Liang S; Yu H; Chen X; Shen T; Cui Z; Si G; Zhang J; Cheng Y; Jia S; Song S; Zhang X; Yu X
    Cell Physiol Biochem; 2017; 41(6):2333-2349. PubMed ID: 28478450
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting RUNX1 as a novel treatment modality for pulmonary arterial hypertension.
    Jeong EM; Pereira M; So EY; Wu KQ; Del Tatto M; Wen S; Dooner MS; Dubielecka PM; Reginato AM; Ventetuolo CE; Quesenberry PJ; Klinger JR; Liang OD
    Cardiovasc Res; 2022 Dec; 118(16):3211-3224. PubMed ID: 35018410
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiomyocyte Sirt (Sirtuin) 7 Ameliorates Stress-Induced Cardiac Hypertrophy by Interacting With and Deacetylating GATA4.
    Yamamura S; Izumiya Y; Araki S; Nakamura T; Kimura Y; Hanatani S; Yamada T; Ishida T; Yamamoto M; Onoue Y; Arima Y; Yamamoto E; Sunagawa Y; Yoshizawa T; Nakagata N; Bober E; Braun T; Sakamoto K; Kaikita K; Morimoto T; Yamagata K; Tsujita K
    Hypertension; 2020 Jan; 75(1):98-108. PubMed ID: 31735083
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA-150 relieves vascular remodeling and fibrosis in hypoxia-induced pulmonary hypertension.
    Li Y; Ren W; Wang X; Yu X; Cui L; Li X; Zhang X; Shi B
    Biomed Pharmacother; 2019 Jan; 109():1740-1749. PubMed ID: 30551428
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Luteolin ameliorates hypoxia-induced pulmonary hypertension via regulating HIF-2α-Arg-NO axis and PI3K-AKT-eNOS-NO signaling pathway.
    Ji L; Su S; Xin M; Zhang Z; Nan X; Li Z; Lu D
    Phytomedicine; 2022 Sep; 104():154329. PubMed ID: 35843187
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pulmonary artery endothelial cell dysfunction and decreased populations of highly proliferative endothelial cells in experimental congenital diaphragmatic hernia.
    Acker SN; Seedorf GJ; Abman SH; Nozik-Grayck E; Partrick DA; Gien J
    Am J Physiol Lung Cell Mol Physiol; 2013 Dec; 305(12):L943-52. PubMed ID: 24124189
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neutralization of CXCL12 attenuates established pulmonary hypertension in rats.
    Bordenave J; Thuillet R; Tu L; Phan C; Cumont A; Marsol C; Huertas A; Savale L; Hibert M; Galzi JL; Bonnet D; Humbert M; Frossard N; Guignabert C
    Cardiovasc Res; 2020 Mar; 116(3):686-697. PubMed ID: 31173066
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reversal of Pulmonary Hypertension in a Human-Like Model: Therapeutic Targeting of Endothelial DHFR.
    Murugesan P; Zhang Y; Huang Y; Chenggong Zong N; Youn JY; Chen W; Wang C; Loscalzo J; Cai H
    Circ Res; 2024 Feb; 134(4):351-370. PubMed ID: 38299369
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Upregulation of Endothelial DKK1 (Dickkopf 1) Promotes the Development of Pulmonary Hypertension Through the Sp1 (Specificity Protein 1)/SHMT2 (Serine Hydroxymethyltransferase 2) Pathway.
    Wang Q; Tian J; Li X; Liu X; Zheng T; Zhao Y; Li X; Zhong H; Liu D; Zhang W; Zhang M; Li M; Zhang M
    Hypertension; 2022 May; 79(5):960-973. PubMed ID: 35249365
    [TBL] [Abstract][Full Text] [Related]  

  • 19. BOLA (BolA Family Member 3) Deficiency Controls Endothelial Metabolism and Glycine Homeostasis in Pulmonary Hypertension.
    Yu Q; Tai YY; Tang Y; Zhao J; Negi V; Culley MK; Pilli J; Sun W; Brugger K; Mayr J; Saggar R; Saggar R; Wallace WD; Ross DJ; Waxman AB; Wendell SG; Mullett SJ; Sembrat J; Rojas M; Khan OF; Dahlman JE; Sugahara M; Kagiyama N; Satoh T; Zhang M; Feng N; Gorcsan J; Vargas SO; Haley KJ; Kumar R; Graham BB; Langer R; Anderson DG; Wang B; Shiva S; Bertero T; Chan SY
    Circulation; 2019 May; 139(19):2238-2255. PubMed ID: 30759996
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reactive oxygen species induced Ca
    Suresh K; Servinsky L; Jiang H; Bigham Z; Yun X; Kliment C; Huetsch J; Damarla M; Shimoda LA
    Am J Physiol Lung Cell Mol Physiol; 2018 May; 314(5):L893-L907. PubMed ID: 29388466
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.